Search results
Results from the WOW.Com Content Network
Novo Nordisk is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply in that market, its CEO said on Wednesday. "In our guidance for the full ...
To try to meet demand, Novo Nordisk said, it has expanded the supply chain by contracting with new manufacturers. It plans to sustain this expansion in 2024 by investing about $6.5 billion in ...
LONDON (Reuters) -Britain's National Health Service and two online sellers told Reuters they had received their first supplies of keenly anticipated Wegovy in Britain on Tuesday, a day after Novo ...
The FDA, in its drug shortage list, listed the 0.25 mg, 0.5 mg and 1 mg doses of the drug with limited availability and that the duration of shortage was "to be decided", while the larger doses of ...
COPENHAGEN (Reuters) -Novo Nordisk's limits on U.S. supplies of starter doses of its hugely popular Wegovy weight-loss drug will last into next year even as the Danish drugmaker spends billions ...
Wegovy was made available in all dose strengths in Denmark in early 2023. A four-week supply costs 2,370.60 Danish crowns ($343). ... Novo Nordisk unless specified otherwise ($1 = 6.8988 Danish ...
Novo shares were trading 1.6% higher at 1038 GMT, even as investors and analysts had hoped for clarity on when limits on the supply of Wegovy starter doses in the U.S. would cease.
COPENHAGEN/LONDON (Reuters) -Novo Nordisk on Wednesday forecast another year of double-digit growth as the Danish drugmaker began boosting U.S. supplies of its popular weight-loss drug Wegovy and ...